EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective

Deepak Kumar, Mahendra Bishnoi, Kanthi Kiran Kondepudi, Shyam Sunder Sharma

Probiotics and Antimicrobial Proteins · 2025-08 · 17 (4) · 2438-2460

DOI: 10.1007/s12602-024-10433-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Probiotics and Antimicrobial Proteins, online erschienen am 15.01.2025. Verfasst von Deepak Kumar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Mohali, Punjab, 160062, India. Hauptthemen laut MEDLINE: Parkinson Disease, Probiotics, Brain-Gut Axis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 198 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent evidence links gut microbiota alterations to neurodegenerative disorders, including Parkinson's disease (PD). Replenishing the abnormal composition of gut microbiota through gut microbiota-based interventions "prebiotics, probiotics, synbiotics, postbiotics, and fecal microbiota transplantation (FMT)" has shown beneficial effects in PD. These interventions increase gut metabolites like short-chain fatty acids (SCFAs) and glucagon-like peptide-1 (GLP-1), which may protect dopaminergic neurons via the gut-brain axis. Neuroprotective effects of these interventions are mediated by several mechanisms, including the enhancement of neurotrophin and activation of the PI3K/AKT/mTOR signaling pathway, GLP-1-mediated gut-brain axis signaling, Nrf2/ARE pathway, and autophagy. Other pathways, such as free fatty acid receptor activation, synaptic plasticity improvement, and blood-brain and gut barrier integrity maintenance, also contribute to neuroprotection. Furthermore, the inhibition of the TLR4/NF-кB pathway, MAPK pathway, GSK-3β signaling pathway, miR-155-5p-mediated neuroinflammation, and ferroptosis could account for their protective effects. Clinical studies involving gut microbiota-based interventions have shown therapeutic benefits in PD patients, particularly in improving gastrointestinal dysfunction and some neurological symptoms. However, the effectiveness in alleviating motor symptoms remains mild. Large-scale clinical trials are still needed to confirm these findings. This review emphasizes the neuroprotective mechanisms of gut microbiota-based interventions in PD as supported by both preclinical and clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseProbioticsBrain-Gut AxisGastrointestinal MicrobiomeDietary SupplementsFecal Microbiota TransplantationHumansAnimalsSignal Transduction

Stichwörter der Autor:innen

Fecal microbiota transplantationGut microbiotaParkinson’s diseasePrebioticProbioticSynbiotic

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Mohali, Punjab, 160062, India.
  • Centre for Excellence in Functional Foods, Division of Food and Nutritional Biotechnology, National Agri-Food Biomanufacturing Institute (NABI), Knowledge City-Sector 81, S.A.S. Nagar, Punjab, 140306, India.
  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Mohali, Punjab, 160062, India. sssharma@niper.ac.in.

Zitieren

APA

Kumar, D., Bishnoi, M., Kondepudi, K. K., & Sharma, S. S. (2025). Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective. Probiotics and Antimicrobial Proteins, 17(4), 2438-2460. https://doi.org/10.1007/s12602-024-10433-x

Vancouver

Kumar D, Bishnoi M, Kondepudi KK, Sharma SS. Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective. Probiotics and Antimicrobial Proteins. 2025;17(4):2438-2460. doi:10.1007/s12602-024-10433-x

BibTeX
@article{Kumar2025,
  author = {Kumar, Deepak and Bishnoi, Mahendra and Kondepudi, Kanthi Kiran and Sharma, Shyam Sunder},
  title = {Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective},
  journal = {Probiotics and Antimicrobial Proteins},
  year = {2025},
  volume = {17},
  number = {4},
  pages = {2438--2460},
  doi = {10.1007/s12602-024-10433-x}
}
Kostenlos starten →